Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002341492 | SCV002641513 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-05-05 | criteria provided, single submitter | clinical testing | The c.5024delT variant, located in coding exon 36 of the NF1 gene, results from a deletion of one nucleotide at nucleotide position 5024, causing a translational frameshift with a predicted alternate stop codon (p.L1675Rfs*2). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Molecular Genetics Laboratory, |
RCV000578376 | SCV000680118 | pathogenic | Neurofibromatosis, type 1 | 2017-06-26 | no assertion criteria provided | clinical testing |